Treg/Th17 imbalance and its clinical significance in patients with hepatitis B-associated liver cirrhosis

Diagn Pathol. 2019 Oct 21;14(1):114. doi: 10.1186/s13000-019-0891-4.

Abstract

Background: Recent studies have shown that T cell-mediated cellular immune mechanisms play important roles in the progression of hepatitis B to liver cirrhosis, but the underlying mechanisms remain unclear. This present study was aimed to determine the relationship between Treg/Th17 and hepatitis B-associated liver cirrhosis.

Methods: The Treg and Th17 cell frequencies in the peripheral blood of all participants, including 93 patients with hepatitis B-associated liver cirrhosis and 40 healthy subjects, were measured by flow cytometer. Cox regression model and receiver operating characteristic(ROC) curves were applied to investigate the prognostic significance of Treg/Th17 ratio in decompensated liver cirrhosis.

Results: We observed the Treg/Th17 imbalance was present in patients with hepatitis B-associated liver cirrhosis, with reduced Treg cells in their peripheral blood, increased Th17 cells and decreased Treg/Th17 ratio. Treg and Th17 cells were negatively correlated. Treg/Th17 imbalance was closely related to the clinical stage of hepatitis B-associated liver cirrhosis. The Virus load, Treg frequencies and the Treg/Th17 ratio were independent factors predicting decompensated liver cirrhosis from a Cox regression model. The ROC analysis showed that the Treg/Th17 ratio was the best marker for predicting decompensated liver cirrhosis.

Conclusions: Treg/Th17 imbalance is involved in the pathogenesis of hepatitis B-associated liver cirrhosis and the Treg/Th17 ratio can be used as a potential marker for predicting decompensated liver cirrhosis.

Keywords: Hepatitis B-associated liver cirrhosis; Immune mechanism; Th17; Treg.

MeSH terms

  • Adult
  • Biomarkers / blood
  • Disease Progression
  • Female
  • Hepatitis B / immunology
  • Hepatitis B / pathology*
  • Hepatitis B, Chronic / complications
  • Humans
  • Liver Cirrhosis / virology*
  • Male
  • Middle Aged
  • T-Lymphocytes, Regulatory / immunology*
  • T-Lymphocytes, Regulatory / virology
  • Th17 Cells / immunology*
  • Th17 Cells / virology

Substances

  • Biomarkers